We are live on ! Find out more
CANY

Caxton Associates (New York) Portfolio holdings

AUM $3.18B
1-Year Est. Return 54.49%
This Fund
S&P 500
This Quarter Est. Return
+10.11%
1 Year Est. Return
+54.49%
3 Year Est. Return
+73.91%
5 Year Est. Return
+212.89%
10 Year Est. Return
+632.2%
AUM
$663M
AUM Growth
-$835M
Cap. Flow
-$859M
Cap. Flow %
-129.52%
Top 10 Hldgs %
36.6%
Holding
684
New
251
Increased
107
Reduced
109
Closed
206

Sector Composition

Rank Sector Weight
1 Materials 20.16%
2 Technology 17.81%
3 Consumer Discretionary 13.64%
4 Healthcare 9.49%
5 Financials 9.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MHK icon
376
Mohawk Industries
MHK
$9.19B
$260K 0.04%
+2,594
New +$283K
SNV
377
DELISTED
Synovus
SNV
$256K 0.04%
+8,310
New +$316K
TAL icon
378
TAL Education Group
TAL
$6.93B
$256K 0.04%
+39,939
New +$288K
TDAY
379
USA Today Co
TDAY
$1.05B
$254K 0.04%
135,648
-18,189
-12% -$42.6K
BBW icon
380
Build-A-Bear
BBW
$467M
$251K 0.04%
+10,816
New +$251K
SBGI icon
381
Sinclair Inc
SBGI
$995M
$251K 0.04%
+14,632
New +$254K
ALDX icon
382
Aldeyra Therapeutics
ALDX
$91.1M
$246K 0.04%
+24,787
New +$175K
SOHU
383
Sohu.com
SOHU
$376M
$246K 0.04%
16,697
-12,897
-44% -$194K
NINE
384
DELISTED
Nine Energy Service
NINE
$246K 0.04%
44,181
-19,143
-30% -$198K
CGBD icon
385
Carlyle Secured Lending
CGBD
$766M
$245K 0.04%
17,979
-11,970
-40% -$176K
GRTS
386
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$244K 0.04%
87,786
-32,348
-27% -$92.4K
AME icon
387
Ametek
AME
$58B
$242K 0.04%
1,667
+28
+2% +$3.98K
KAMN
388
DELISTED
Kaman Corp
KAMN
$240K 0.04%
10,494
-10,275
-49% -$245K
ELAN icon
389
Elanco Animal Health
ELAN
$11.1B
$240K 0.04%
+25,485
New +$301K
WSO icon
390
Watsco Inc
WSO
$13.5B
$239K 0.04%
752
-4,626
-86% -$1.36M
SEIC icon
391
SEI Investments
SEIC
$12.6B
$236K 0.04%
4,104
+599
+17% +$35.9K
TUP
392
DELISTED
Tupperware Brands Corporation
TUP
$234K 0.04%
+93,529
New +$345K
MSCI icon
393
MSCI
MSCI
$40.9B
$233K 0.04%
+416
New +$220K
FOSL icon
394
Fossil Group
FOSL
$317M
$232K 0.03%
72,386
-99,986
-58% -$449K
TRUE
395
DELISTED
TrueCar
TRUE
$230K 0.03%
100,095
-13,583
-12% -$36.2K
TCS
396
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
$230K 0.03%
4,465
+1,722
+63% +$115K
NATI
397
DELISTED
National Instruments Corp
NATI
$226K 0.03%
4,308
-11,863
-73% -$595K
CBAY
398
DELISTED
Cymabay Therapeutics
CBAY
$224K 0.03%
25,725
-47,924
-65% -$384K
VRSK icon
399
Verisk Analytics
VRSK
$23.6B
$224K 0.03%
+1,167
New +$211K
TREE icon
400
LendingTree
TREE
$453M
$224K 0.03%
+8,392
New +$275K

Similar funds

Caxton Associates (New York)'s Q1 2023 Portfolio in Review

As of Q1 2023, Caxton Associates (New York) held 684 positions worth $663M, down 56% from $1.5B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Caxton Associates (New York) withdrew a net $859M in Q1 2023, closing 206 positions and reducing 109 holdings. Its most notable exit was iShares Biotechnology ETF, an estimated $152M position sold in full.

By sector, the portfolio is most concentrated in Materials at 20% of assets, up from 0.33% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Caxton Associates (New York) opened a new position in Advanced Micro Devices worth $14.8M.

  • Caxton Associates (New York)'s largest Q1 2023 buy was Advanced Micro Devices: 151,421 shares worth $14.8M.
  • Caxton Associates (New York) added most to Freeport-McMoran in Q1 2023, an estimated $123M increase.
  • Caxton Associates (New York)'s biggest Q1 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $541M.
  • Caxton Associates (New York) fully exited iShares Biotechnology ETF in Q1 2023, selling an estimated $152M.
  • Caxton Associates (New York)'s ten largest holdings make up 37% of its $663M portfolio in Q1 2023.
  • Caxton Associates (New York) opened 251 new positions and closed 206 in Q1 2023.
  • Caxton Associates (New York)'s portfolio value fell 56% quarter-over-quarter to $663M.

Based on Caxton Associates (New York)'s 13F filing for Q1 2023, filed 15 May 2023.